KMTS

Business Context and Reporting Period

Company: Kestra Medical Technologies, Ltd. (KMTS)
Filing Type: Form 8-K (Current Report)
Date of Report: December 1, 2025
Reporting Period: Fiscal quarter ended October 31, 2025
Context: The Company issued a press release announcing preliminary estimated financial results for the quarter. The filing incorporates the press release as Exhibit 99.1 but explicitly states that the financial information is not deemed "filed" for purposes of Section 18 of the Exchange Act.

Key Financial Metrics

The provided text contains only the cover page and standard legal disclaimers of the Form 8-K. It references a press release (Exhibit 99.1) containing the actual numbers but does not include the text of that press release.

• Revenue: Not provided in the filing text.
• Profit/Loss: Not provided in the filing text.
• Cash Flow: Not provided in the filing text.
• Margins: Not provided in the filing text.
• Debt and Liquidity: Not provided in the filing text.

Note: The filing text does not provide a clear value for any specific financial metric.

Material Changes

No specific material changes regarding financial performance versus the prior comparable period are detailed in the provided text. The filing serves solely as a notification that preliminary results have been announced.

Guidance, Outlook, and Risks

Forward-Looking Statements: The filing includes extensive disclaimers regarding forward-looking statements, noting they are subject to significant uncertainties and are preliminary unaudited estimates.

Identified Risks: The text lists several factors that could cause actual results to differ materially from projections:

• Limited operating history and history of net losses.
• Ability to achieve substantial market adoption of products.
• Competitive pressures.
• Adaptability of manufacturing and production capacities to demand.
• Product defects, complaints, and related liability.
• Ability to obtain and maintain adequate coverage and reimbursement levels.
• Compliance with changing laws and regulatory requirements.
• Dependence on a limited number of suppliers.

Guidance: No specific numerical guidance or outlook figures are present in the text.

Investor Verification Checklist

• Verify the specific preliminary revenue and net loss figures in the attached Press Release (Exhibit 99.1), as they are not in the main text.
• Confirm the status of product reimbursement levels and coverage, cited as a key risk factor.
• Review the Company's history of net losses and limited operating history as referenced in the risk factors.
• Check for any updates on manufacturing capacity constraints or supplier dependencies.
• Monitor future filings for the audited financial statements, as current results are preliminary estimates.